4//SEC Filing
Monohon Ted 4
Accession 0001209191-23-016507
CIK 0001662774other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:55 PM ET
Size
5.0 KB
Accession
0001209191-23-016507
Insider Transaction Report
Form 4
Monohon Ted
Chief Accounting Officer
Transactions
- Sale
Common Stock
2023-03-06$0.98/sh−1,871$1,834→ 27,440 total
Footnotes (1)
- [F1]Represents shares sold to satisfy tax withholding obligations that arose in connection with the vesting of 4,250 shares of Restricted Stock Units granted on March 3, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2022.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001606905
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:55 PM ET
- Size
- 5.0 KB